EP1292283A4 - Formulation aerosol medicale - Google Patents

Formulation aerosol medicale

Info

Publication number
EP1292283A4
EP1292283A4 EP01901681A EP01901681A EP1292283A4 EP 1292283 A4 EP1292283 A4 EP 1292283A4 EP 01901681 A EP01901681 A EP 01901681A EP 01901681 A EP01901681 A EP 01901681A EP 1292283 A4 EP1292283 A4 EP 1292283A4
Authority
EP
European Patent Office
Prior art keywords
aerosol formulation
medicinal aerosol
medicinal
formulation
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01901681A
Other languages
German (de)
English (en)
Other versions
EP1292283A1 (fr
Inventor
Akwete L Adjei
Yaping Zhu
John Z Sun
Simon Stefanos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeropharm Technology LLC
Original Assignee
Aeropharm Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/702,195 external-priority patent/US6585957B1/en
Application filed by Aeropharm Technology LLC filed Critical Aeropharm Technology LLC
Publication of EP1292283A4 publication Critical patent/EP1292283A4/fr
Publication of EP1292283A1 publication Critical patent/EP1292283A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
EP01901681A 2000-01-25 2001-01-02 Formulation aerosol medicale Withdrawn EP1292283A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US702195 1985-02-15
US17798700P 2000-01-25 2000-01-25
US177987P 2000-01-25
US09/702,195 US6585957B1 (en) 2000-01-25 2000-10-30 Medicinal aerosol formulation
PCT/US2001/000117 WO2001060420A1 (fr) 2000-01-25 2001-01-02 Formulation aerosol medicale

Publications (2)

Publication Number Publication Date
EP1292283A4 true EP1292283A4 (fr) 2003-03-19
EP1292283A1 EP1292283A1 (fr) 2003-03-19

Family

ID=26873842

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01901681A Withdrawn EP1292283A1 (fr) 2000-01-25 2001-01-02 Formulation aerosol medicale

Country Status (6)

Country Link
EP (1) EP1292283A1 (fr)
JP (1) JP2003524646A (fr)
CN (1) CN1440298A (fr)
AU (1) AU783120B2 (fr)
CA (1) CA2396796C (fr)
MX (1) MXPA02007187A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4707327B2 (ja) * 2004-01-27 2011-06-22 旭化成ファーマ株式会社 ポリペプタイド類の吸着防止剤
ES2281222B1 (es) * 2004-09-24 2008-06-01 Grifols, S.A. Utilizacion de alfa-1 antitripsina para la preparacion de medicamentos para el tratamiento de la fibromialgia.
CA2666794C (fr) 2006-10-18 2017-12-12 Periness Ltd. Methode et composition pharmacologique destinees au diagnostic et au traitement de la sous-fertilite masculine
US11471617B2 (en) * 2014-04-03 2022-10-18 Csl Behring Ag Nebultzation of immunoglobulin
CN104162142A (zh) * 2014-08-29 2014-11-26 宁波市微循环与莨菪类药研究所 N-乙酰天门冬氨酰谷氨酸二肽制剂在海洛因成瘾治疗中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257956A2 (fr) * 1986-08-19 1988-03-02 Genentech, Inc. Dispositif et dispersion pour l'administration intrapulmonaire de facteurs de croissance et de cytocines polypeptides
WO1995024183A1 (fr) * 1994-03-07 1995-09-14 Inhale Therapeutic Systems Procede et preparations pour l'administration d'insuline par voie pulmonaire
WO2000016814A1 (fr) * 1998-09-22 2000-03-30 Aeropharm Technology Incorporated Formulation d'aerosol medicinal
WO2001049274A2 (fr) * 1999-12-30 2001-07-12 Chiron Corporation Procedes d'administration pulmonaire d'interleukine-2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689424B1 (fr) * 1993-03-17 1998-10-14 Minnesota Mining And Manufacturing Company Formulation pour aerosol contenant un adjuvant de dispersion derive d'un ester, d'un amide ou d'un mercaptoester

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0257956A2 (fr) * 1986-08-19 1988-03-02 Genentech, Inc. Dispositif et dispersion pour l'administration intrapulmonaire de facteurs de croissance et de cytocines polypeptides
WO1995024183A1 (fr) * 1994-03-07 1995-09-14 Inhale Therapeutic Systems Procede et preparations pour l'administration d'insuline par voie pulmonaire
WO2000016814A1 (fr) * 1998-09-22 2000-03-30 Aeropharm Technology Incorporated Formulation d'aerosol medicinal
WO2001049274A2 (fr) * 1999-12-30 2001-07-12 Chiron Corporation Procedes d'administration pulmonaire d'interleukine-2

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KOEHLER D: "SYSTEMIC THERAPY WITH AEROSOLS", AEROSOLS IN MEDICINE. PRINCIPLES, DIAGNOSIS AND THERAPY, 1993, pages 303 - 319, XP002942706 *
See also references of WO0160420A1 *

Also Published As

Publication number Publication date
AU2755901A (en) 2001-08-27
CA2396796C (fr) 2011-06-21
CN1440298A (zh) 2003-09-03
JP2003524646A (ja) 2003-08-19
AU783120B2 (en) 2005-09-29
CA2396796A1 (fr) 2001-08-23
EP1292283A1 (fr) 2003-03-19
MXPA02007187A (es) 2002-12-09

Similar Documents

Publication Publication Date Title
EP1296723A4 (fr) Preparation medicamenteuse pour aerosol
AU2753001A (en) A medicinal aerosol formulation
AU4519001A (en) A medicinal aerosol formulation
AU2001224716A1 (en) A medicinal aerosol formulation
AU2001226233A1 (en) A medicinal aerosol formulation
HUP0302311A3 (en) Medicinal aerosol formulations
EP1250127A4 (fr) Procede d'administration d'une formulation aerosol medicale
AU1233002A (en) Medicament dispenser
PL343491A1 (en) Pharmaceutical aerosol formulation
HK1045465A1 (en) A pharmaceutical formulation comprising megalatranand its prodrug
HUP0300405A3 (en) Aerosol inhaler
AU2001224718A1 (en) A medicinal aerosol formulation
AU2623401A (en) A medicinal aerosol formulation
AU2001259318A1 (en) A medicinal aerosol formulation
HUP0600143A2 (en) A stable pharmaceutical formulation comprising torsemide modification ii
GB9924992D0 (en) Pharmaceutical aerosol formulations
EP1292283A4 (fr) Formulation aerosol medicale
AU2001227531A1 (en) A medicinal aerosol formulation
AU2001247123A1 (en) A medicinal aerosol formulation
GB0014849D0 (en) Pharmaceutical aerosol formulation
GB0013400D0 (en) A formulation
GB0014851D0 (en) Novel pharmaceutical formulation
GB0014947D0 (en) Novel pharmaceutical formulation
GB0014892D0 (en) Novel pharmaceutical formulation
GB0014883D0 (en) Novel pharmaceutical formulation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020812

A4 Supplementary search report drawn up and despatched

Effective date: 20030122

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17Q First examination report despatched

Effective date: 20061128

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120801